Sarissa Capital Management LP

Sarissa Capital Management LP reported 10 holdings worth US$153M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Sarissa Capital Management LP reported 10 holdings worth US$153M as of Sep 30, 2026. Largest: Innoviva, Inc., Ironwood Pharmaceuticals, Inc. and Amarin Corporation plc. Filed Nov 16, 2026 (Form 13F).

Holdings
10
Value as reported
US$153M

The filing in full

CompanySharesValue as reported% of portfolio
Innoviva, Inc.1.89MUS$40.1M26.2%
Ironwood Pharmaceuticals, Inc.9.19MUS$36.5M23.8%
Amarin Corporation plc1.29MUS$16.7M10.9%
Lantheus Holdings, Inc.167KUS$16.6M10.8%
Neurocrine Biosciences, Inc.117KUS$16.5M10.8%
Cytokinetics, Incorporated229KUS$15.1M9.8%
Biohaven Ltd.582KUS$7.77M5.1%
Regeneron Pharmaceuticals, Inc.4,190US$3.18M2.1%
Vor Biopharma Inc.25,399US$485K0.32%
Biogen Inc.950US$215K0.14%

Source

Download original · View original at SEC

Related